The Future Of Immunotherapy Evolving

Ritu Salani, MD, MBA, UCLA Health in Los Angeles, CA, discusses the promising

Biochemist Lingyin Li survived breast cancer at just 30 and now works to harness the human immune system to fight cancers that ...

... with pioneering experts who have shaped the past present and

UPMC and the University of Pittsburgh are once again partnering to advance the pace of life-

Aaron Logan, MD, PhD, assistant professor of Clinical Medicine, University of California San Francisco, discusses the

This session is a deeper dive into

In the early 1980's, doctors and scientists were experimenting with a revolutionary cancer treatment known as

Cancer Research UK scientists may have found the tools necessary to give

Course Director, David L. Rimm, MD, PhD, discusses cancer

Cancer is a formidable foe, but what if we could turn the enemy into an ally? V Foundation Grantee, Dr. Bingfei Yu, explores the ...

Providing a historical perspective on uh

Dr. Bingfei Yu, a leading cancer researcher supported by the V Foundation, discusses a revolutionary new approach to treatment ...

... the chemotherapy is not going to give me long-term effect um but this they're hoping is something that will this is

Glenn Lesser, MD, Wake Forest School of Medicine, Winston-Salem, NC, discusses the journey of

IMMUNOTHERAPY

Alexander Van Akkooi, MD, PhD, Melanoma Institute Australia, Sydney, Australia, comments on the

Louis M. Weiner, MD, explains that checkpoint inhibitors represent a promising treatment option for essentially all types of cancer, ...

This talk was given at a local TEDx event, produced independently of the TED Conferences. How will we cure cancer in

shorts A revolutionary cancer breakthrough is

Madhav Dhodapkar, MBBS, clinical research program leader, Hematology Program, Yale Cancer Center, discusses the